World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5055)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

121

WORD

HTML

2724

Figures (1-1)

419

Tables (1-5)

431

Sum=3719

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

216

Download

918

Sum=1134

Feb 15, 2024 (publication date) through Jul 21, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Meng M, Shi LL. Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus. World J Diabetes 2024; 15(2): 232-239 [PMID: 38464372 DOI: 10.4239/wjd.v15.i2.232]
URL:	https://www.wjgnet.com/1948-9358/full/v15/i2/232.htm

Number	Citing Articles
1	Xiafei Zhao, Yan Wang, Ling Zhou, Aili Ye, Quanfeng Zhu. Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-85807-4
2	Iman Mohammad Said Jallod, Ammar Khalo Abbas, Faheemah Ismael Yaqoob, Abdul-Aziz Ahmed Aziz. Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04209-5
3	Hongwei Qian, Yanhua Huang, Yuxing Dong, Luohang Xu, Ruanchang Chen, Fangzheng Zhou, Difan Zhou, Jianhua Yu, Baochun Lu. A combined radiomics and clinical model for preoperative differentiation of intrahepatic cholangiocarcinoma and intrahepatic bile duct stones with cholangitis: a machine learning approach. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1546940
4	Kotha Sugunakar Reddy, Ilakkiya Priya Pandiaraj, Archana Gaur, Sakthivadivel Varatharajan. Serum tumor markers: Can they clinically implicate in type 2 diabetes mellitus?. World Journal of Diabetes 2024; 15(7): 1648-1650 doi: 10.4239/wjd.v15.i7.1648 Abstract(491) \| Core Tip(500) \| Full Article(HTML)(968) \| Full Article with Cover (PDF)-567K(82) \| Audio-661K(5) \| Peer-Review Report-169K(89) \| Answering Reviewers-52K(72) \| Full Article (PDF)-333K(108) \| Full Article (XML)-22K(80) \| Times Cited (0) \| Total Visits (3905) \| Open
5	Xinxin Wo, Xiaoyan Yu, Lingling Miao, Yushan Mao, Keke Tang. Diabetic Ketoacidosis in Klinefelter Syndrome Sans Malignancy with Unusually Elevated Levels of CEA: A Case Report. Diabetes, Metabolic Syndrome and Obesity 2025; : 233 doi: 10.2147/DMSO.S498230
6	Li Tao, Tong Yao, Yan Zhang, Yangyang Gong, Lun Huang, Ya Zhao, Naichuan Chen, Jian Yin, Li Xue, Chaoliang Xiong, Xuanxi Li, YanPing Zhang. Association between serum tumor markers and diabetic nephropathy in type 2 diabetes patients: a cross-sectional survey in Western China. BMC Endocrine Disorders 2025; 25(1) doi: 10.1186/s12902-025-01932-1